Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7717525

Concept 2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-09-30
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
Key financial data of group
Business results of group
Net sales
50,360,000,000 JPY
110,640,000,000 JPY
50,758,000,000 JPY
Ordinary profit (loss)
3,183,000,000 JPY
9,345,000,000 JPY
1,693,000,000 JPY
Profit (loss) attributable to owners of parent
2,217,000,000 JPY
6,574,000,000 JPY
1,240,000,000 JPY
Comprehensive income
3,992,000,000 JPY
9,132,000,000 JPY
2,181,000,000 JPY
Net assets
164,618,000,000 JPY
163,297,000,000 JPY
157,501,000,000 JPY
Total assets
196,255,000,000 JPY
196,736,000,000 JPY
188,544,000,000 JPY
Basic earnings (loss) per share
15.44
30.04
89.28
-15.66
16.86
Diluted earnings per share
Equity-to-asset ratio
0.839 xbrli:pure
0.830 xbrli:pure
0.835 xbrli:pure
Net cash provided by (used in) operating activities
7,297,000,000 JPY
10,456,000,000 JPY
7,260,000,000 JPY
Net cash provided by (used in) investing activities
-2,185,000,000 JPY
-6,038,000,000 JPY
-3,928,000,000 JPY
Net cash provided by (used in) financing activities
-3,627,000,000 JPY
-3,735,000,000 JPY
-2,685,000,000 JPY
Cash and cash equivalents
44,660,000,000 JPY
42,971,000,000 JPY
43,137,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.